#BEGIN_DRUGCARD DB03833

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H17N3O2

# Chemical_IUPAC_Name:
2-tert-butyl-5-{[(2S)-pyrrolidin-2-yl]carbonyl}-1,3,4-oxadiazole

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole

# HET_ID:
PTB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H17N3O2/c1-11(2,3)10-14-13-9(16-10)8(15)7-5-4-6-12-7/h7,12H,4-6H2,1-3H3/t7-/m0/s1

# InChI_Key:
InChIKey=YUKGJYBQODPVBL-ZETCQYMHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3833

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
223.2716

# Molecular_Weight_Mono:
223.132076803

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1WM1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.12

# Predicted_LogS:
-2.6

# Predicted_Water_Solubility:
5.24e-01 g/l

# Primary_Accession_No:
DB03833

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
449137

# PubChem_Substance_ID:
46506788

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02680

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@]1(CCCN1)C(=O)C1=NN=C(O1)C(C)(C)C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:40 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D87897

# Drug_Target_1_GenBank_ID_Protein:
2605615

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pip

# Drug_Target_1_Gene_Sequence:
>954 bp
ATGGAACAATTACGAGGTTTGTACCCGCCGTTAGCGGCATACGACAGCGGTTGGCTGGAT
ACTGGGGATGGCCACCGGATCTACTGGGAGCTGAGCGGTAACCCGAACGGTAAACCGGCG
GTATTCATTCACGGCGGGCCGGGCGGCGGCATCTCCCCGCATCATCGTCAGCTGTTCGAT
CCCGAACGCTACAAGGTGCTGCTGTTCGATCAGCGCGGTTGCGGCCGCTCCCGTCCGCAT
GCCAGCCTGGACAACAACACCACCTGGCATTTGGTGGCCGATATCGAGCGGCTGCGCGAA
ATGGCCGGCGTCGAGCAGTGGCTGGTGTTCGGCGGTTCCTGGGGATCGACGCTGGCGCTC
GCCTATGCGCAGACCCACCCGGAGCGCGTCAGTGAAATGGTGCTGCGCGGCATCTTCACC
CTGCGCAAGCAGAGGCTGCATTGGTATTACCAGGACGGCGCTTCGCGCTTCTTCCCGGAA
AAATGGGAGCGCGTGCTGTCCATCCTCTCGGATGACGAGCGTAAAGACGTGATCGCCGCC
TACCGGCAGCGGCTGACCTCGGCCGATCCGCAGGTGCAGCTTGAAGCGGCCAAACTGTGG
AGCGTGTGGGAAGGGGAGACGGTCACGCTGCTGCCGAGCCGCGAATCCGCTTCGTTCGGC
GAGGATGATTTCGCGCTGGCGTTCGCCCGCATTGAAAACCACTACTTCACCCATCTGGGC
TTCCTGGAAAGCGACGACCAACTGCTGCGCAACGTGCCGCTGATCCGCCATATTCCGGCG
GTGATCGTCCACGGCCGCTATGACATGGCCTGCCAGGTGCAGAACGCCTGGGACCTGGCC
AAGGCCTGGCCGGAGGCGGAGCTGCATATCGTGGAAGGGGCGGGGCATTCGTATGATGAG
CCGGGCATTTTGCACCAGCTGATGATCGCCACCGACCGGTTTGCCGGCAAATGA

# Drug_Target_1_General_Function:
Involved in hydrolase activity

# Drug_Target_1_General_References:
10467172	Yoshimoto T, Kabashima T, Uchikawa K, Inoue T, Tanaka N, Nakamura KT, Tsuru M, Ito K: Crystal structure of prolyl aminopeptidase from Serratia marcescens. J Biochem (Tokyo). 1999 Sep;126(3):559-65.
11011150	Ito K, Inoue T, Kabashima T, Kanada N, Huang HS, Ma X, Azmi N, Azab E, Yoshimoto T: Substrate recognition mechanism of prolyl aminopeptidase from Serratia marcescens. J Biochem (Tokyo). 2000 Oct;128(4):673-8.
9348090	Kabashima T, Kitazono A, Kitano A, Ito K, Yoshimoto T: Prolyl aminopeptidase from Serratia marcescens: cloning of the enzyme gene and crystallization of the expressed enzyme. J Biochem (Tokyo). 1997 Sep;122(3):601-5.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3614

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
36084

# Drug_Target_1_Name:
Proline iminopeptidase

# Drug_Target_1_Number_of_Residues:
317

# Drug_Target_1_PDB_ID:
1WM1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_1_Protein_Sequence:
>Proline iminopeptidase
MEQLRGLYPPLAAYDSGWLDTGDGHRIYWELSGNPNGKPAVFIHGGPGGGISPHHRQLFD
PERYKVLLFDQRGCGRSRPHASLDNNTTWHLVADIERLREMAGVEQWLVFGGSWGSTLAL
AYAQTHPERVSEMVLRGIFTLRKQRLHWYYQDGASRFFPEKWERVLSILSDDERKDVIAA
YRQRLTSADPQVQLEAAKLWSVWEGETVTLLPSRESASFGEDDFALAFARIENHYFTHLG
FLESDDQLLRNVPLIRHIPAVIVHGRYDMACQVQNAWDLAKAWPEAELHIVEGAGHSYDE
PGILHQLMIATDRFAGK

# Drug_Target_1_Reaction:
Release of N-terminal proline from a peptide ALL_REAC (other) R00135 COFACTOR Manganese

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Specifically catalyzes the removal of N-terminal proline residues from peptides

# Drug_Target_1_SwissProt_ID:
O32449

# Drug_Target_1_SwissProt_Name:
PIP_SERMA

# Drug_Target_1_Synonyms:
EC 3.4.11.5
PAP
PIP
Prolyl aminopeptidase

# Drug_Target_1_Theoretical_pI:
6.23

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03833
